Today’s News

Last Updated: Friday, August 1, 2014, 2:40 pm

Amalgamated Bank Names Mestrich CEO

Amalgamated Bank announced Keith Mestrich was selected as CEO to support its growth and further its mission of offering affordable and accessible banking for all.

MidCap Adds Perfetti as SVP to New Business Team

MidCap Business Credit announced it appointed Michael Perfetti to its business development team.

Hercules Growth Capital Provides Celladon $25MM Facility

Celladon announced it entered into a credit facility with Hercules Technology Growth Capital and its affiliate lenders. The facility provides for up to $25 million of loans.

Matrix Promotes Underwood to Director

Matrix Capital Markets Group announced John J. Underwood was promoted to director in the Energy & Multi-Site Retail Industry Group.

Cerberus Provides Aurora Revolver, Term Loan

Aurora Diagnostics announced it entered into a facility with Cerberus Business Finance. The agreement includes a $165 million term loan, $30 million revolver and $25 million delayed draw term loan facility.

Ares Management, GE Capital Provide InfoVista Unitranche Debt

Ares Management and GE Capital International have provided a $62.3 million debt facility to French firm InfoVista through the firms’ $2.3 billion joint venture, the European Senior Secured Loan Programme.

Crystal Financial Provides Sports Chalet Financing

Crystal Financial announced it provided a $15 million term loan to Sports Chalet.

GE Capital, Others Finance Nautic Partners Acquisition

Nautic Partners announced that it has partnered with management to acquire Custom Window Systems. GE Capital, Jefferies, Newstar Financial and Triangle Capital provided financing for the transaction.

JPMorgan Funds Polyester Fibers Management Buyout

Polyester Fibers completed a management-led buyout from its parent company, Empire Investment Holdings. The buyout was funded by Polyester Fibers’ management team and financing was provided by JPMorgan Chase.

SVB Provides $20MM in Debt Financing to Fate Therapeutics

Fate Therapeutics announced it completed a long-term debt financing of up to $20 million with Silicon Valley Bank.